Close
13/12/2017
ALBA Synchrotron Works for People’s Health
Two recent works remind us that ALBA synchrotron is a very valuable tool to help develop new drugs.

On one hand, using the MIRAS beam line of the ALBA synchrotron (infrared radiations), researchers from the Universitat Autònoma de Barcelona (UAB) and the ALBA Synchrotron have demonstrated in a paper the capability of metalosomes - aggregates made of phospholipids and metal complexes - to interact with cells and release carbon monoxide in a controlled way (CO release can be beneficial because of its anti-inflammatory, vasodilator and cardio protective properties).
 
On the other hand, in another publication, a team led by researchers from the Universitat Politècnica de Catalunya (UPC) has unveiled the mechanism of action of two drugs, FR60 and JNI18, which cure 100% of mice with sleeping sickness. Using X-rays of the ALBA XALOC beam line, they have observed how these drugs perfectly stacked on the Trypanosoma brucei’s DNA, the parasite that causes the disease (image). Blocking and inflicting specific damage on its DNA, the parasite cannot reproduce and finally dies after 4-5 days.
 

More news

08/02/2018 ERC Grants & the Catalan Research System: a Success Story 01/02/2018 The best of the Bioregion of Catalonia in 2017 25/01/2018 Barcelona, a business friendly capital 18/01/2018 When Ideas Generated at the UAB make cows happy 11/01/2018 2017, the Year When Stradivarius settled Down In the Barcelona Synchrotron Park 21/12/2017 Barcelona Supercomputing Center: Beautiful, Powerful And European
12 13 14 15 16 17 18 19 20 21 22